GENE ONLINE|News &
Opinion
Blog

Richard Chau

WRITTEN BY Richard Chau

U.S.-German Joint Discovery May Spark Breakthrough in Diabetes Research
2023-03-29
Merck Regains Worldwide Rights to BAVENCIO After Parting Ways with Pfizer
2023-03-29
Incyte’s Zynyz Secures FDA Approval for Treating a Rare and Aggressive Skin Cancer
2023-03-23
Kite’s Yescarta Yields a Success in a Phase 3 Trial for Treating Large B-Cell Lymphoma
2023-03-22
Biogen’s Tofersen May Show Clinical Benefit in ALS Patients with Rare SOD1 Mutations
2023-03-21
HHS Issues Initial Guidance on Negotiation Program as Government’s Latest Move to Reduce Drug Prices
2023-03-21
Sanofi Slashes Insulin Prices by Up to 78% Following Hot On the Heels of Major Competitors
2023-03-19
Amgen Faces Class Action Lawsuit for Concealing $10.7 Billion Tax Bill to Manipulate Stock Price
2023-03-16
Novo Nordisk Announces Major Insulin Price Cut by Up to 75%, Following in the Footsteps of Eli Lilly
2023-03-15
Pfizer Acquires Seagen for $43 Billion to Capture Leading Position in Oncology
2023-03-14
Biotech Start-ups May Face a Foreboding Prospect Following Silicon Valley Bank (SVB)’s Unsuspected Collapse
2023-03-14
Lilly’s New Alzheimer’s Drug Suffers Setback as Phase 3 Results Fall Short of Expectations
2023-03-10
Exciting Cell & Gene Therapy Research Updates in Glaucoma and Nerve Regeneration
2023-03-08
Global Head of Research of Kite Pharma Unveiled the Key Elements to Success in Adoptive Cell Therapy
2023-03-07
Reata’s Groundbreaking Therapy for an Ultra-rare Neuromuscular Disease Secures FDA Approval
2023-03-02
1 4 5 6 7 8 9
Scroll to Top